RÁČIL, Zdeněk, Ludmila MALÁSKOVÁ, Markéta VYSKOČILOVÁ, Filip RÁZGA, Lucie BUREŠOVÁ, Daniela ŽÁČKOVÁ and Jiří MAYER. Imatinib (IMA) plasma concentration (PC) monitoring and its correlation with treatment response in chronic myelogenous leukemia (CML): a single centre experience. In Haematologica. 2010;95(s2):528. 2010.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Imatinib (IMA) plasma concentration (PC) monitoring and its correlation with treatment response in chronic myelogenous leukemia (CML): a single centre experience
Authors RÁČIL, Zdeněk, Ludmila MALÁSKOVÁ, Markéta VYSKOČILOVÁ, Filip RÁZGA, Lucie BUREŠOVÁ, Daniela ŽÁČKOVÁ and Jiří MAYER.
Edition Haematologica. 2010;95(s2):528, 2010.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
UT WoS 000279051301619
Tags International impact, Reviewed
Changed by Changed by: doc. MUDr. Daniela Žáčková, Ph.D., učo 203252. Changed: 12/3/2014 18:40.
PrintDisplayed: 3/5/2024 15:56